News
Neteera Technologies, an Israeli-based startup disrupting the contactless patient monitoring market, has announced the successful closing of a $6.7 million Series B extension. The round was led by Aescuvest, a healthcare investment firm, alongside Foxconn Technology Co (FTC), an associate of Hon Hai Precision Industry, a large electronics manufacturer globally.
The Consumer Technology Association (CTA) announced that HD Hyundai, the world’s largest shipbuilder, will keynote at CES 2024 to share tech-first strategies which employ technology for building a more sustainable future. HD Hyundai, a global company also known for specialised construction equipment and energy solutions, further excels in developing eco-friendly infrastructure technology, as well as retrofitting carriers and shipyards.
The Consumer Technology Association (CTA) announced Gail K. Boudreaux, president and CEO of Elevance Health, will headline a keynote session to discuss how the company is implementing an innovative whole-health approach to care. It complements the Digital Health Summit, which returns to CES 2024, and will focus on the outlook for health care in the U.S. and beyond.
Nearly 70 startups, plus hundreds of attendees and media from around the globe convened yesterday for CES Unveiled Amsterdam. The event highlighted tech innovation from European startups that will solve global challenges and conference programming addressing sustainability, healthcare, climate change, and tech trends—including digital health, enterprise, AI, and a look toward using tech for good.
Multiple startups have been recognised at the Touristech Startup Fest 2023, the global entrepreneurship competition hosted annually by TIS – Tourism Innovation Summit. The event, which has positioned itself as the key event for the tourism and technology entrepreneurial ecosystem, received more than 4,000 applications from startups from countries such as Spain, Austria, Belgium, Germany, Italy, the Netherlands, Norway, Portugal, Sweden, the United Kingdom and the United States.
Upfront Diagnostics, a healthcare company focused on discovering novel biomarkers that can be applied to medical diagnosis, has started the last phase of clinical evaluation of a point-of-care rapid blood test designed to rapidly identify when stroke is caused by a blood clot blocking a main blood vessel within the brain. This is known as large vessel occlusion (LVO).













